ATA406877A - Verfahren zur herstellung neuer alkinole - Google Patents

Verfahren zur herstellung neuer alkinole

Info

Publication number
ATA406877A
ATA406877A AT406877A AT406877A ATA406877A AT A406877 A ATA406877 A AT A406877A AT 406877 A AT406877 A AT 406877A AT 406877 A AT406877 A AT 406877A AT A406877 A ATA406877 A AT A406877A
Authority
AT
Austria
Prior art keywords
lightweight
building block
concrete building
concrete
block
Prior art date
Application number
AT406877A
Other languages
English (en)
Other versions
AT360971B (de
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ATA406877A publication Critical patent/ATA406877A/de
Application granted granted Critical
Publication of AT360971B publication Critical patent/AT360971B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
AT406877A 1976-06-10 1977-06-08 Verfahren zur herstellung neuer alkinole AT360971B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762626018 DE2626018A1 (de) 1976-06-10 1976-06-10 Alkinole und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ATA406877A true ATA406877A (de) 1980-07-15
AT360971B AT360971B (de) 1981-02-10

Family

ID=5980233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT406877A AT360971B (de) 1976-06-10 1977-06-08 Verfahren zur herstellung neuer alkinole

Country Status (15)

Country Link
US (1) US4151294A (de)
JP (1) JPS52151138A (de)
AT (1) AT360971B (de)
AU (1) AU510322B2 (de)
BE (1) BE855575A (de)
CA (1) CA1084516A (de)
DE (1) DE2626018A1 (de)
ES (1) ES459654A1 (de)
FR (1) FR2354309A1 (de)
GB (1) GB1538417A (de)
IL (1) IL52274A (de)
IT (1) IT1078469B (de)
NL (1) NL7706401A (de)
SE (1) SE7706724L (de)
ZA (1) ZA773484B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1104589A (en) * 1978-06-27 1981-07-07 Rudolf Wehrli Alcohols
US4528114A (en) * 1981-12-18 1985-07-09 Hoffmann-La Roche Inc. Acetylenes
US5155196A (en) * 1987-06-01 1992-10-13 The Dow Chemical Company Polymer resulting from the cure of a preformed chromene-containing mixture

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969415A (en) * 1971-12-01 1976-07-13 Sandoz, Inc. 1-(2-Naphthyl)-2,3-butadien-1-ols
US3929902A (en) * 1972-01-19 1975-12-30 Sandoz Ag 1-Phenyl-2, 3-butadien-1-ols
US3888933A (en) * 1973-12-28 1975-06-10 Sandoz Ag 4-hydroxyethyl-biphenylyl-butadienols
US3879449A (en) * 1974-03-04 1975-04-22 Sandoz Ag 1-Phenyl-4-hydroxy-1-buten-3-ones and esters thereof
US3939278A (en) * 1974-07-05 1976-02-17 Eli Lilly And Company Phenoxyphenyl-acetylenes and thio analogues thereof as antithrombotic agents
DE2519719A1 (de) * 1975-05-02 1976-11-18 Merck Patent Gmbh Phenylalkanole und verfahren zu ihrer herstellung
DE2528958A1 (de) * 1975-06-28 1977-01-13 Merck Patent Gmbh Araliphatische dihalogenverbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE2626018A1 (de) 1977-12-22
JPS52151138A (en) 1977-12-15
SE7706724L (sv) 1977-12-11
ES459654A1 (es) 1978-12-01
US4151294A (en) 1979-04-24
FR2354309B1 (de) 1981-01-09
BE855575A (nl) 1977-12-12
IL52274A (en) 1980-02-29
AT360971B (de) 1981-02-10
NL7706401A (nl) 1977-12-13
AU2549977A (en) 1978-11-30
GB1538417A (en) 1979-01-17
CA1084516A (en) 1980-08-26
FR2354309A1 (fr) 1978-01-06
IT1078469B (it) 1985-05-08
AU510322B2 (en) 1980-06-19
IL52274A0 (en) 1977-08-31
ZA773484B (en) 1978-04-26

Similar Documents

Publication Publication Date Title
IL52440A0 (en) Building block
AU496856B1 (en) Improved building block
JPS5323746A (en) Building blocks
ZA774636B (en) Building structures
JPS5349547A (en) Building block set
ZA773891B (en) Building block
JPS52108616A (en) Building
JPS5336917A (en) Building structure
JPS5641864A (en) Concrete
JPS5370529A (en) Building
ATA406877A (de) Verfahren zur herstellung neuer alkinole
JPS5311643A (en) Building blocks
JPS5363734A (en) Building
ZA761200B (en) Building elements
GB1547209A (en) Building members
JPS5358102A (en) Concrete block
AU1507476A (en) Building system
JPS52118932A (en) Sounddproof building structure
JPS5324312A (en) Concrete
JPS5310519A (en) Improved building structure
KR780001501Y1 (en) Mutti-purpose concrete block
JPS5237138A (en) Building blocks
ZA763111B (en) Buildings
JPS5349846A (en) Highhstorey building structure
JPS52142811A (en) Building method

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee